Triple negative breast cancer (TNBC) is a subtype of breast cancer that lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) following immunohistochemical analysis [1]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.